Malaysia grants conditional approval for Thai-made AstraZeneca vaccine
KUALA LUMPUR — Malaysian health authorities said on Friday (June 4) conditional approval had been granted for AstraZeneca's Covid-19 vaccine manufactured by Siam Bioscience in Thailand.
Malaysia has purchased 12.8 million doses of AstraZeneca's vaccine, half through the Covax facility and the remainder directly from the drugmaker.
Quiz of the week
How well do you know the news? Test your knowledge.
KUALA LUMPUR — Malaysian health authorities said on Friday (June 4) conditional approval had been granted for AstraZeneca's Covid-19 vaccine manufactured by Siam Bioscience in Thailand.
Malaysia’s health director-general, Dr Noor Hisham Abdullah, said in a statement the vaccine supply received from Thailand is expected to speed up implementation of Malaysia's national vaccination programme.
The government had previously put the AstraZeneca vaccine in a parallel optional programme after reports of possible links to very rare blood clots.
But the vaccine was brought back into the national immunisation programme last week after hundreds of thousands of people scrambled to get the shot.
Malaysia has purchased 12.8 million doses of AstraZeneca's vaccine, half through the Covax facility and the remainder directly from the drugmaker.
The first shipment of 610,000 doses from Thailand is scheduled for this month, followed by 410,000 doses in July and 1.2 million doses between August and September, the government had said previously. REUTERS
Related topics
Covid-19 coronavirus Malaysia vaccine AstraZeneca ThailandStay in the know. Anytime. Anywhere.
Subscribe to our newsletter for the top features, insights and must reads delivered straight to your inbox.
By clicking subscribe, I agree for my personal data to be used to send me TODAY newsletters, promotional offers and for research and analysis.
